Jul 9, 2021
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, participated in the second leg of the Biotechnology Innovation Organization (“BIO”) Digital, a premier international biotech partnering event held virtually on June 10-11 and 14-18, 2021, through its three subsidiaries. “While informative, the thrust of attending for companies like that of Predictive Oncology is networking and one-on-one sessions that can result in new partnerships or customers,” reads a recent article. “‘In previous conferences, Soluble Biotech has typically received more than a dozen requests for proposals, leading to new contracts for their main service of providing protein therapeutic formulations (i.e., formulations for vaccines, antibodies, virus-like particles),’ said Predictive Oncology CEO J. Melville Engle. He added that the Helomics unit is leveraging BIO’s one-on-one sessions to showcase its precision medicine discovery platform branded ‘PeDAL’… The conference allowed TumorGenesis to market its products and services specialized on culturing cancer cells from ovarian and breast cancers that more accurately mimic a patient’s tumors.”
To view the full article, visit https://ibn.fm/dZ5uo
About Predictive Oncology Inc.
Predictive Oncology operates through three segments (Skyline, Helomics and Soluble Biotech), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. TumorGenesis Inc. specializes in media that help cancer cells grow and retain their DNA/RNA and proteomic signatures, providing researchers with a tool to expand and study cancer cell types found in tumors of the blood and organ systems of all mammals, including humans. Skyline Medical markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. Soluble Biotech is a provider of soluble and stable formulations for proteins, including vaccines, antibodies, large and small proteins and protein complexes. For more information, visit the company’s website at www.Predictive-Oncology.com.
NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork
Alaska is taking its Boeing 737 MAX across the North Pacific, launching nonstop Anchorage–Tokyo flights with an eight-hour journey that presents unusual operational challenges and passenger considerations. The post Eight Hours Over the Pacific in a 737? Alaska Airlines Says Yes appeared first on Business Traveller.
All my seafood haters, rise up! View Entire Post ›
Many frequent flyers, including me, think the experience is getting worse. View Entire Post ›
Backed by the business group behind travel management company COTRAV, the new venture draws on the group’s experience in managing travel and logistics for large events, weddings and concerts. COTRAV BLACK will operate as a distinct brand focused on premium live-entertainment experiences.
Christmas market season is approaching, but beyond Europe’s best-known festive destinations, some of the continent’s most atmospheric celebrations can be found further north. Across Norway, Sweden, Finland and Iceland, Christmas markets take over historic squares, open-air museums and even forests, bringing together local crafts, Nordic design, seasonal food and traditions that have been celebrated for generations. For travellers looking for something a little different this winter, Nordic travel specialist Off The Map Travel has selected six Christmas markets worth putting on the radar for 2026, from Stockholm’s century-old Skansen market to Bergen’s enormous gingerbread city.
Sofia, the capital of Bulgaria and one of Europe’s oldest cities, will once again embrace the magic of Christmas with Sofia Christmas Fest 2026. From 20 November to 28 December, the festival will return for its fifth consecutive year to the park in front of the National Palace of Culture (NDK), an iconic convention and cultural centre located in the heart of the city.
As someone who grew up spellbound by Charlie and the Chocolate Factory, I've perhaps been guilty of harbouring an idealised view of industrial-scale production lines.
Former ESPN reporter and Fox News personality Britt McHenry has stepped down from her role as press adviser for the US Department of State. The development comes after viral videos appeared to show her throwing a drink at someone (after one was allegedly thrown at her) during an altercation in the stands at an NBA game. Page Six reported that McHenry was “forced to resign” on Thursday, a day after the incident at the Washington Wizards’ home opener against the Milwaukee Bucks at Capital One...
The Daily Mail's travel desk brings you a selection of the best deals currently available - so you can bag a bargain break.
2/5 stars In Michihito Fujii’s romantic drama You, Like a Star, Suzu Hirose and Ryusei Yokohama play young lovers trapped in a turbulent, decades-spanning relationship that defines their lives. Adapted from the novel by Yuu Nagira, who provided the source material for the actors’ last on-screen collaboration, Wandering (2022), the drama touches on intriguing and volatile topics without ever daring to broach them fully. The result is a polished but aggressively generic chronicle of romantic...
The Palm Jumeirah landmark is welcoming guests back with a reimagined bar, live piano performances, and its signature rituals from 1 November The post The St. Regis Dubai, The Palm Announces Reopening Date appeared first on Business Traveller.
Adam Brody, who plays rabbi Noah Roklov in Netflix’s hit romcom Nobody Wants This, condemned the ongoing Israel-Gaza war during an interview with GQ magazine in September this year. “Put me down as thinking it’s a genocide,” Brody told the magazine. “Put me down as wanting a free Palestine.” The 46-year-old Jewish actor’s comments have drawn backlash from fans as well as some members of the Jewish community, including his Nobody Wants This co-star Tovah Feldshuh. In an interview with the New...
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.